Related Experiment Video
Updated: Mar 9, 2026
12:27
A Pipeline to Investigate the Structures and Signaling Pathways of Sphingosine 1-Phosphate Receptors
Published on: June 8, 2022
4.0K
Sphingosine 1-Phosphate Receptor Modulators and Drug Discovery
1Molecular Inflammation Research Center for Aging Intervention (MRCA) and College of Pharmacy, Pusan National University, Busan 46241, Republic of Korea.
Biomolecules & Therapeutics
|December 31, 2016
Summary
Sphingosine 1-phosphate (S1P) pathways, initially intracellular, are now key therapeutic targets. Drug discovery efforts focus on S1P receptor modulators for autoimmune and inflammatory diseases.
Area of Science:
- Biochemistry
- Pharmacology
- Immunology
Background:
- Sphingosine 1-phosphate (S1P) was initially identified as an intracellular second messenger.
- Subsequent research revealed S1P's role as a first messenger, leading to the discovery of its five G protein-coupled receptors (S1P₁₋₅).
- This discovery opened new avenues for understanding the pathophysiology of S1P signaling.
Approach:
- Utilized in vitro cellular and molecular studies.
- Employed in vivo studies using gene-deficient mice to elucidate signaling pathways.
- Investigated the pathophysiological roles of S1P receptors.
Key Points:
- Fingolimod (FTY720), an S1P receptor modulator, accelerated drug discovery and was approved for relapsing multiple sclerosis.
- Ongoing clinical trials explore S1P receptor modulators for various autoimmune and inflammatory conditions.
- Development of more selective S1P receptor modulators with improved pharmacokinetic profiles and reduced side effects is underway.
Conclusions:
- S1P receptor modulation represents a significant therapeutic strategy.
- Targeting S1P receptors holds promise for treating multiple sclerosis and other immune-mediated diseases.
- Continued research and development are crucial for optimizing S1P-targeted therapies.
More Related Videos
Related Concept Videos
01:28Structure-Activity Relationships and Drug Design
1.9K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.9K
01:26Drug Discovery: Overview
12.5K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
12.5K
01:26Targets for Drug Action: Overview
10.9K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
10.9K
01:27Transducer Mechanism: Enzyme-Linked Receptors
4.6K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
4.6K
01:29Pharmacogenomics: Identification of New Drug Targets
57
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
57
01:15G Protein-coupled Receptors
18.6K
G Protein-Coupled Receptors or GPCRs are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to sensory stimuli such as light, odors, hormones, cytokines, or neurotransmitters.
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
18.6K